Altrazeal Life Sciences Inc.
Altrazeal Life Sciences Inc. is a specialty medical technology company dedicated to developing and commercializing innovative drug delivery systems. Their mission is to improve patient outcomes by providing comprehensive solutions for patients, providers, and payers. The company is known for its patented Altrazeal® Transforming Powder Dressing, which optimizes the wound healing environment and supports tissue repair.
Altrazeal Life Sciences Inc.
Altrazeal Life Sciences Inc. 15020 Beltway Drive Addison, TX 75001 United States of America
What We Do
A patented powder dressing engineered to optimize the wound bed environment and accelerate healing. It forms a moist, flexible, oxygen-permeable film that fits and seals the wound, allowing for extended wear time of up to 30 days.
A novel, patented, water-erodible pharmaceutical carrier device that adheres to mucosal surfaces, delivering actives to treat localized diseases. It provides tailored erosion rates for drug release over different time intervals.
Routes of Administration
FDA Regulated Medical Devices
Key People
Chairperson, CEO
COO, Director
VP Special Projects, Director
Director
Director
Board Observer
Funded Projects
Developing an Ideal Wound Care Platform - Altrazeal Transforming Powder
ULURU Inc., supported by NAMD and MTEC, is advancing Altrazeal®, a novel wound care technology designed for extended wear in acute and chronic wounds. Altrazeal’s polymer-based powder forms a protective, oxygen-permeable matrix, reducing dressing changes and promoting healing. Already in use in civilian and veteran health systems, MTEC funding is accelerating clinical trials and expanding adoption. Additional grants support its use in military, surgical, and low-resource settings worldwide.
News & Updates
This article discusses the innovative use of transforming powder dressing in treating various chronic wounds.
This study evaluates the cost-effectiveness of using transforming powder dressing compared to standard wound care.
This article presents outcomes from three patients treated with transforming powder dressing for chronic venous leg ulcers.